Innovative
therapies for autoimmune diseases
The future of medicine lies in the intersection of biology and technology, and we are committed to pioneering that future.
More about usAbout PolTREG
The first administration of TREGs in humans
17 years of experience in cell therapies
The first in the race to the market
Phase 2 study successfully completed in type 1 diabetes
Partner of choice in autoimmune diseases
Expertise, people and production facility
PolTREG
mission
Our mission is to develop effective cell therapies for the treatment of autoimmune diseases that positively impact the quality of life for patients and their families.
